Zangar RC - Search Results

1

Mechanisms that regulate production of reactive oxygen species by cytochrome P450.

Zangar RC, Davydov DR, Verma S. Zangar RC, et al. Toxicol Appl Pharmacol. 2004 Sep 15;199(3):316-31. doi: 10.1016/j.taap.2004.01.018. Toxicol Appl Pharmacol. 2004. PMID: 15364547 Review.

2

The nuclear factor-kappa B pathway regulates cytochrome P450 3A4 protein stability.

Zangar RC, Bollinger N, Verma S, Karin NJ, Lu Y. Zangar RC, et al. Mol Pharmacol. 2008 Jun;73(6):1652-8. doi: 10.1124/mol.107.043976. Epub 2008 Mar 11. Mol Pharmacol. 2008. PMID: 18334598

3

Reactive oxygen species alter autocrine and paracrine signaling.

Zangar RC, Bollinger N, Weber TJ, Tan RM, Markillie LM, Karin NJ. Zangar RC, et al. Free Radic Biol Med. 2011 Dec 1;51(11):2041-7. doi: 10.1016/j.freeradbiomed.2011.09.001. Epub 2011 Sep 10. Free Radic Biol Med. 2011. PMID: 21963990 Free PMC article.

4

Interactions of phospholipase D and cytochrome P450 protein stability.

Zangar RC, Fan YY, Chapkin RS. Zangar RC, et al. Biochem Pharmacol. 2004 Aug 1;68(3):503-12. doi: 10.1016/j.bcp.2004.04.004. Biochem Pharmacol. 2004. PMID: 15242816

5

Cytochrome P450 3A conjugation to ubiquitin in a process distinct from classical ubiquitination pathway.

Zangar RC, Kimzey AL, Okita JR, Wunschel DS, Edwards RJ, Kim H, Okita RT. Zangar RC, et al. Mol Pharmacol. 2002 Apr;61(4):892-904. doi: 10.1124/mol.61.4.892. Mol Pharmacol. 2002. PMID: 11901229

6

Differential effects of ciprofibrate on renal and hepatic cytochrome P450 2E1 expression.

Zangar RC, Woodcroft KJ, Novak RF. Zangar RC, et al. Toxicol Appl Pharmacol. 1996 Nov;141(1):110-6. doi: 10.1006/taap.1996.0266. Toxicol Appl Pharmacol. 1996. PMID: 8917682

7

Diet-induced obesity reprograms the inflammatory response of the murine lung to inhaled endotoxin.

Tilton SC, Waters KM, Karin NJ, Webb-Robertson BJ, Zangar RC, Lee KM, Bigelow DJ, Pounds JG, Corley RA. Tilton SC, et al. Among authors: zangar rc. Toxicol Appl Pharmacol. 2013 Mar 1;267(2):137-48. doi: 10.1016/j.taap.2012.12.020. Epub 2013 Jan 7. Toxicol Appl Pharmacol. 2013. PMID: 23306164 Free PMC article.

8

Suppression of cytochrome P450 3A protein levels by proteasome inhibitors.

Zangar RC, Kocarek TA, Shen S, Bollinger N, Dahn MS, Lee DW. Zangar RC, et al. J Pharmacol Exp Ther. 2003 Jun;305(3):872-9. doi: 10.1124/jpet.102.044628. Epub 2003 Mar 6. J Pharmacol Exp Ther. 2003. PMID: 12626652

9

Hydroperoxy-10,12-octadecadienoic acid stimulates cytochrome P450 3A protein aggregation by a mechanism that is inhibited by substrate.

Kimzey AL, Weitz KK, Guengerich FP, Zangar RC. Kimzey AL, et al. Among authors: zangar rc. Biochemistry. 2003 Nov 4;42(43):12691-9. doi: 10.1021/bi0349975. Biochemistry. 2003. PMID: 14580217

10

Susceptibility to quantum dot induced lung inflammation differs widely among the Collaborative Cross founder mouse strains.

Scoville DK, White CC, Botta D, McConnachie LA, Zadworny ME, Schmuck SC, Hu X, Gao X, Yu J, Dills RL, Sheppard L, Delaney MA, Griffith WC, Beyer RP, Zangar RC, Pounds JG, Faustman EM, Kavanagh TJ. Scoville DK, et al. Among authors: zangar rc. Toxicol Appl Pharmacol. 2015 Dec 1;289(2):240-50. doi: 10.1016/j.taap.2015.09.019. Epub 2015 Oct 21. Toxicol Appl Pharmacol. 2015. PMID: 26476918 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74 results

Search Page